Detalles de la búsqueda
1.
Characterization of a novel anti-PVRIG antibody with Fc-competent function that exerts strong antitumor effects via NK activation in preclinical models.
Cancer Immunol Immunother
; 73(5): 81, 2024 Mar 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38554184
2.
Snapshot spectral imaging based on aberration model-driven deep learning.
Opt Lett
; 49(11): 2894-2897, 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38824286
3.
Characterization of anti-CD79b/CD3 bispecific antibody, a potential therapy for B cell malignancies.
Cancer Immunol Immunother
; 72(2): 493-507, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35963895
4.
Combined strategies for effective cancer immunotherapy with a novel anti-CD47 monoclonal antibody.
Cancer Immunol Immunother
; 71(2): 353-363, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34165607
5.
Integrated analysis to identify the AC005154.6/hsa-miR-29c-3p/CCNL2 axis as a novel prognostic biomarker associated with immune infiltration in prostate cancer.
Cancer Cell Int
; 22(1): 346, 2022 Nov 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36369040
6.
Tumor-selective blockade of CD47 signaling with a CD47/PD-L1 bispecific antibody for enhanced anti-tumor activity and limited toxicity.
Cancer Immunol Immunother
; 70(2): 365-376, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32761423
7.
Development and characterization of a novel anti-OX40 antibody for potent immune activation.
Cancer Immunol Immunother
; 69(6): 939-950, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32078015
8.
Assessment of treatment outcomes: cytoreductive surgery compared to radiotherapy in oligometastatic prostate cancer - an in-depth quantitative evaluation and retrospective cohort analysis.
Int J Surg
; 2024 Mar 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38498388
9.
STX4 as a potential biomarker for predicting prognosis and guiding clinical treatment decisions in clear cell renal cell carcinoma.
Heliyon
; 10(1): e23918, 2024 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38226288
10.
MiRNA-100 ameliorates diabetes mellitus-induced erectile dysfunction by modulating autophagy, anti-inflammatory, and antifibrotic effects.
Andrology
; 2024 Jan 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38227138
11.
CPT2-mediated fatty acid oxidation inhibits tumorigenesis and enhances sorafenib sensitivity via the ROS/PPARγ/NF-κB pathway in clear cell renal cell carcinoma.
Cell Signal
; 110: 110838, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37541641
12.
Dual-Functional Tunable Metasurface for Meta-Axicon with a Variable Depth of Focus and Continuous-Zoom Metalens.
Nanomaterials (Basel)
; 13(18)2023 Sep 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37764559
13.
Anti-PD-1/Her2 Bispecific Antibody IBI315 Enhances the Treatment Effect of Her2-Positive Gastric Cancer through Gasdermin B-Cleavage Induced Pyroptosis.
Adv Sci (Weinh)
; 10(30): e2303908, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37587833
14.
Pharmacology, pharmacokinetics, and toxicity characterization of a novel anti-CD73 therapeutic antibody IBI325 for cancer immunotherapy.
Int J Biol Macromol
; 229: 158-167, 2023 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36587633
15.
Genome-Wide Splicing Quantitative Expression Locus Analysis Identifies Causal Risk Variants for Non-Small Cell Lung Cancer.
Cancer Res
; 83(10): 1742-1756, 2023 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36939399
16.
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells.
Nat Cancer
; 4(9): 1309-1325, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37550516
17.
Identification of a Gene Signature to Aid Treatment Decisions by Integrated Analysis of Mutated Genes Between Primary and Metastatic Prostate Cancer.
Front Genet
; 13: 877086, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35495154
18.
LMO3 downregulation in PCa: A prospective biomarker associated with immune infiltration.
Front Genet
; 13: 945151, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36199576
19.
A predictive signature based on enhancer RNA associates with immune infiltration and aids treatment decision in clear cell renal cell carcinoma.
Front Oncol
; 12: 964838, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36313627
20.
IBI379, a novel B cell maturation antigen/CD3 bispecific T-cell engager, displays high antitumor efficacy in preclinical models of multiple myeloma.
Cancer Lett
; 536: 215663, 2022 06 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35381307